CHARGEPAC 55

SECTION 2: Hazards identification

OSHA Emergency Overview Appearance: solid, granular, white NOTICE: WHILE THIS MATERIAL HAS A LOW LEVEL OF TOXICITY, GOOD INDUSTRIAL HYGIENE PRACTICES ARE ENCOURAGED TO MINIMIZE EXPOSURE.

Principle Routes of Exposure

Inhalation, Skin contact, Eye Contact, Ingestion Eye contact Dust can cause eye irritation. Symptoms include stinging, tearing, redness, and swelling of eyes. Skin contact Unlikely to cause skin irritation or injury. Ingestion Swallowing small amounts of this material during normal handling is not likely to cause harmful effects. Swallowing large amounts may be harmful. Inhalation This material is a dust or may produce dust. Prolonged or repeated breathing of this material may result in chronic bronchitis (inflammation of the airways of the lungs). Symptoms include coughing and shortness of breath. Symptoms are not expected at air concentrations below the recommended exposure limits, if applicable (see Section 8.).

Medical Conditions Generally Aggravated by Exposure

No data. Page 1 / 10 Page: 2 SAFETY DATA SHEET Revision Date: 10/16/2014 Print Date: 3/6/2015 MSDS Number: 000000228104 Zalta™ MF1735 FLOCCULANT Version: 1.2 ™ Trademark, Solenis or its subsidiaries or affiliates, registered in various countries 818530 Symptoms No data. Target Organs No data. Carcinogenicity This material is not listed as a carcinogen by the International Agency for Research on Cancer (IARC), the National Toxicology Program (NTP), or the Occupational Safety and Health Administration (OSHA). Reproductive hazard Based on the available information, risk to the fetus from maternal exposure to this material cannot be assessed.